5-Year Outcomes from PACE B: An International Phase III Randomized Controlled Trial Comparing Stereotactic Body Radiotherapy (SBRT) vs. Conventionally Fractionated or Moderately Hypo Fractionated (LBA 03)
N. van As, A. Tree, J. Patel, P. Ostler, H. Van Der Voet, D. A. Loblaw, W. Chu, D. Ford, S. Tolan, S. Jain, J. G. Armstrong, P. Camilleri, K. Kancherla, J. Frew, A. Chan, O. Naismith, G. Manning, S. Brown, C. Griffin, and E. Hall | ASTRO | 2023
Multifocal MRI-Directed Simultaneous Integrated Boost (SIB) in the Treatment of Prostate Cancer with Stereotactic Body Radiation Therapy (SBRT) (2866)
J. C. Hurwitz, V. Santos, M. Akerman, C. Mendez, A. Sanchez, A. Corcoran, A. Katz, H. Lepor, S. Taneja, T. J. Carpenter, A. J. Evans, A. Mahadevan, J. A. Haas, and J. W. Lischalk | ASTRO | 2023
Robotic SBRT in Prostate Cancer Patients Younger Than 50 Years Old-Updated Results (2913)
C. Mendez, J. W. Lischalk, A. Katz, T. J. Carpenter, M. R. Witten, A. Sanchez, V. Santos, A. Corcoran, E. Awad, I. Trivedi, S. R. Blacksburg, and J. Haas | ASTRO | 2023
Hypo-fractionated Radiotherapy with SpaceOAR for Prostate Cancer Treated with Radixact TomoTherapy
Sumeyra Can, Didem Karaçetin, Hamza Tatlı, Özge Atilla, Nilgül Nalbant | PO-1818 | ESTRO | 2023
Salvage stereotactic body radiotherapy in oligometastatic gynaecological cancer
Martina Midulla, Andrei Fodor, Flavia Zerbetto, Chiara Lucrezia Deantoni, Roberta Tummineri, Laura Giannini, Sara Broggi, Miriam Torrisi, Federica Ferrario, Chiara Chissotti, Stefano Lorenzo Villa, Paola Mangili, Claudio Fiorino, Stefano Arcangeli, Nadia Gisella Di Muzio | PD-0813 | ESTRO | 2023
Impact of the VOLO Optimizer on Treatment Plan Quality of Stereotactic Prostate Radiotherapy
T. Viren, J. Seppälä | PO-2052 | ESTRO | 2023
Stereotactic Radiotherapy of Prostate Cancer Patients – Two Techniques Comparison: Preliminary Results
Aleksandra Napieralska, Wojciech Majewski, Marcela Krzempek, Grzegorz Woźniak, Marcin Miszczyk, Małgorzata Kraszkiewicz, Agnieszka Namysł-Kaletka | PO-2047 | ESTRO | 2023
Stereotactic Salvage Radiotherapy for Prostate Bed Relapse, Early Analysis from a Prospective Trial
Giulio Francolini, Luca Burchini, Vanessa Di Cataldo, Beatrice Detti, Mauro Loi, Giulio Frosini, Barbara Guerrieri, Michele Ganovelli, Andrea Allegra, Viola Salvestrini, Luca Visani, Emanuela Olmetto, Carlotta Becherini, Gabriele Simontacchi, Manuele Roghi, Maria Grazia Carnevale, Isacco Desideri, Icro Meattini, Lorenzo Livi | PO-1459 | ESTRO | 2023
Stereotactic Focused Radiotherapy for Low-risk Prostate Cancer: Results of a Phase-II Trial
Paul Nguyen, Bertrand Donneaux, Céline Louis, Szusa Bodgal, Sven Philippi, Bérangère Frédérick, Sylvie Biver, Ludovic Harzé, Yves Lasar, Guillaume Vogin, Philippe Nickers | PO-1458 | ESTRO | 2023
Stereotactic Reirradiation for Locally Recurrent Prostate Cancer after Definitive Radiotherapy
Giulio Francolini et al | PD-0576 | ESTRO | 2023
Stereotactic Radiotherapy for Prostate Cancer with Bilateral Hip Replacements
Jakub Cvek et al | RSS | 2023
Organ-Preservation with Concurrent Immunotherapy and Radiotherapy in Bladder Cancer
Imanol Paguey Garrido et al | RSS | 2023
Single-Fraction PSMA-PET- and Multiparametric MRI-Guided Focal SBRT for Prostate Cancer Local Recurrences
Felix Ehret et al | RSS | 2023
Robotic SBRT in Prostate Cancer Patients Younger Than 50 Years Old-Updated Results
Christopher Mendez et al | RSS | 2023
2486: Correlation between Obesity and Treatment Failure Following Stereotactic Body Radiation Therapy (SBRT) for Clinically Localized Prostate Cancer
D. Conroy, T. Sholklapper, M. K. K. Lawlor, J. M. Cantalino, A. Zwart, M. J. Ayoob, M. Danner, T. Yung, B. T. Collins, S. Lei, A. Rashid, D. Kumar, S. Suy, N. Aghdam, and S. P. Collins | ASTRO | 2022
194: Penile Bulb Dose Predicts Sexual Quality of Life after Prostate SBRT: Secondary Analysis of a Multi-Institutional Trial
K. P. Lui, K. Wang, R. C. Chen, B. L. Kane, C. A. Medbery III, K. Underhill Jr, J. R. Gray, A. V. Peddada, and D. B. Fuller | ASTRO | 2022
3195: Real-World Dose Delivery Accuracy of Prostate SBRT with Tomotherapy Based Target Tracking
L. Goddard, J. Tang, M. K. Garg, W. R. Bodner III, P. Brodin, K. Jeong, and W. A. Tome | ASTRO | 2022
Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial
Tree AC, Ostler P, van der Voet H, Chu W, Loblaw A, Ford D, Tolan S, Jain S, Martin A, Staffurth J, Armstrong J, Camilleri P, Kancherla K, Frew J, Chan A, Dayes IS, Duffton A, Brand DH, Henderson D, Morrison K, Brown S, Pugh J, Burnett S, Mahmud M, Hinder V, Naismith O, Hall […]
Efficacy and toxicity of chemoradiation in patients with anal cancer–a retrospective analysis
Koerber SA, Slynko A, Haefner MF, Krug D, Schoneweg C, Kessel K, Kopp-Schneider A, Herfarth K, Debus J, Sterzing F | Radiat Oncol | 2014
Patient reported quality of life after helical IMRT based concurrent chemoradiation of locally advanced anal cancer
Joseph K, Vos LJ, Warkentin H, Paulson K, Polkosnik LA, Usmani N, Tankel K, Severin D, Nijjar T, Schiller D, Wong C, Ghosh S, Mulder K, Field C | Radiother Oncol | 2016
